BREAKING
Kiniksa Pharmaceuticals International (KNSA) Reports Q1 2026 Numbers 6 minutes ago Incyte Q1 2026 EPS Tops Expectations by 29.3%, Revenue Up 21% 6 minutes ago Sportradar Group Reports Q1 2026 Loss, Misses Estimates 8 minutes ago Commvault Systems Releases Q4 2026 Financial Results 11 minutes ago Stepan Tops Q1 2026 Profit Forecast With $0.45 EPS 20 minutes ago Axogen Q1 2026: Revenue Hits $61.5M, Up 27% Year-Over-Year 21 minutes ago Opera Releases Q1 2026 Financial Results 28 minutes ago Shutterstock Releases Q1 2026 Financial Results 30 minutes ago Sherwin-Williams Releases Q1 2026 Financial Results 32 minutes ago LGI Homes Releases Q1 2026 Financial Results 35 minutes ago Kiniksa Pharmaceuticals International (KNSA) Reports Q1 2026 Numbers 6 minutes ago Incyte Q1 2026 EPS Tops Expectations by 29.3%, Revenue Up 21% 6 minutes ago Sportradar Group Reports Q1 2026 Loss, Misses Estimates 8 minutes ago Commvault Systems Releases Q4 2026 Financial Results 11 minutes ago Stepan Tops Q1 2026 Profit Forecast With $0.45 EPS 20 minutes ago Axogen Q1 2026: Revenue Hits $61.5M, Up 27% Year-Over-Year 21 minutes ago Opera Releases Q1 2026 Financial Results 28 minutes ago Shutterstock Releases Q1 2026 Financial Results 30 minutes ago Sherwin-Williams Releases Q1 2026 Financial Results 32 minutes ago LGI Homes Releases Q1 2026 Financial Results 35 minutes ago
ADVERTISEMENT
Breaking News

Coca-Cola Releases Q1 2026 Financial Results

The Coca-Cola Company exceeded Wall Street expectations in the first quarter of 2026, posting comparable earnings per share of $0.

April 28, 2026 2 min read

The Coca-Cola Company exceeded Wall Street expectations in the first quarter of 2026, posting comparable earnings per share of $0.

AlphaStreet Newsdesk powered by AlphaStreet Intelligence

KOKO|EPS $0.86 vs $0.84 est (+2.4%)|Rev $12.50B

The Coca-Cola Company exceeded Wall Street expectations in the first quarter of 2026, posting comparable earnings per share of $0.86 against analyst estimates of $0.84. The beverage giant’s beat of 2.4% signals continued momentum in its global portfolio of nonalcoholic drinks.

Revenue climbed to $12.50B for the quarter, representing a 12.0% increase from the $11.13B recorded in Q1 2025. The Atlanta-based company reported organic revenue growth of 10.0% for the period, reflecting strong underlying demand across its diverse brand portfolio that spans carbonated soft drinks, juices, sports beverages, and ready-to-drink coffee and tea products.

The performance comes as Coca-Cola continues to navigate shifting consumer preferences in both developed and emerging markets. The company’s ability to drive double-digit revenue growth while expanding margins demonstrates the strength of its global distribution network and pricing power across categories.

Wall Street maintains a bullish stance on the stock, with analyst consensus standing at 20 buy ratings, 6 hold ratings, and zero sell recommendations. The strong first quarter sets a positive tone as the company enters the crucial summer selling season for beverages.

A detailed analysis of The Coca-Cola Company’s quarter follows shortly on AlphaStreet.

This content is for informational purposes only and should not be considered investment advice. AlphaStreet Intelligence analyzes financial data using AI to deliver fast and accurate market information. Human editors verify content.

ADVERTISEMENT